Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Pharm Belg ; (2): 20-9, 2015 Jun.
Article in French | MEDLINE | ID: mdl-26466506

ABSTRACT

PURPOSE: In France, efforts to optimize prescribing of proton-pump inhibitors (PPIs) are rare. Various studies have shown that the prescription of these drugs is excessive. This has consequences regarding costs and iatrogenesis. The objective of this study was to describe the type of drug related problems (DRP) and pharmaceutical interventions reported by pharmacists practicing in a university hospital. METHODS: Drug related problems and pharmaceutical interventions (PI) made, were recorded on a database. They were classified according to the grid code of the French Society of Clinical Pharmacy. RESULTS AND DISCUSSION: Over a 3 years period, 132.890 prescriptions were analysed. 15.347 generated PI. Among them 701 (4.6%) concerned PPIs. Most frequently reported problems were: lack of indication or patients without a documented indication (24.4%), drug-drug interactions (22.4%) and inappropriate route or mode of administration (19.8%). Discontinuation has been proposed in 40.5% of cases, followed by substitution (22.0%) and dosage titration (17.3%). Physicians modified the prescription according to 51.3% of PI. The main PI, discontinuation therapy, is associated with over-prescription of this drug class. Nevertheless, the rate of DRP recorded (0.5%) is low compared to the high exposure of patients on PPIs and misuse (or overuse?) reported in the literature. CONCLUSION: PI made during the analysis of prescription contributes to rationalizing the use of PPIs. The action of the pharmacist must be strengthened through training of health professionals, and communication strategies to improve practices.


Subject(s)
Hospitals, University/organization & administration , Pharmacists , Pharmacy Service, Hospital/organization & administration , Proton Pump Inhibitors/adverse effects , Drug Prescriptions/standards , Humans , Medication Errors/prevention & control , Proton Pump Inhibitors/therapeutic use
3.
Bull Soc Pathol Exot ; 104(1): 53-7, 2011 Feb.
Article in French | MEDLINE | ID: mdl-21243460

ABSTRACT

To assess the extent and severity of poisoning by Atractylis gummifera L. in Morocco, a descriptive retrospective study was conducted on all the poisoning cases listed between 1981 and 2004 to the Morocco Poison Control Center. During this period, 240 people were hospitalized for glue thistle poisoning, 72% of which are children under 16 years. The severity of the poisoning has been affirmed by significant intrahospital lethality. Indeed, among the 182 patients for whom the outcomes were known, 98 died (54%).


Subject(s)
Atractylis/poisoning , Plant Poisoning/epidemiology , Poison Control Centers/statistics & numerical data , Accidents/statistics & numerical data , Adolescent , Adult , Child , Child, Preschool , Female , Hospitalization/statistics & numerical data , Humans , Infant , Male , Middle Aged , Morocco/epidemiology , Plant Poisoning/etiology , Plant Poisoning/mortality , Retrospective Studies , Rural Population/statistics & numerical data , Suicide, Attempted/statistics & numerical data , Urban Population/statistics & numerical data , Young Adult
4.
Ann Pharm Fr ; 68(5): 269-74, 2010 Sep.
Article in French | MEDLINE | ID: mdl-20849997

ABSTRACT

SUMMARY: Pregnant women are at increased risk of severe complications associated with H1N1 pandemic influenza. Fever and inflammatory syndrome associated with the infection may also be deleterious for the developing fetus. Therefore, early antiviral treatment is recommended. Oseltamivir and zanamivir are the two therapeutic options available indicated in the treatment of H1N1 influenza; however, limited data is published on their use during pregnancy and lactation. In this review, we will focus on the effects of H1N1 during pregnancy and on data safety of antivirals during pregnancy and lactation. Main health authorities recommendations for H1N1 influenza treatment of pregnant women will also be presented.


Subject(s)
Antiviral Agents/adverse effects , Antiviral Agents/therapeutic use , Breast Feeding , Influenza A Virus, H1N1 Subtype , Influenza, Human/drug therapy , Adult , Female , Fetus/drug effects , Humans , Influenza Vaccines/adverse effects , Influenza Vaccines/therapeutic use , Influenza, Human/prevention & control , Oseltamivir/therapeutic use , Pregnancy , Zanamivir/therapeutic use
7.
Ann Dermatol Venereol ; 130(1 Pt 1): 43-6, 2003 Jan.
Article in French | MEDLINE | ID: mdl-12605157

ABSTRACT

INTRODUCTION: Juvenile hyaline fibromatosis is a rare hereditary genetic disease characterized by a cutaneous tumoral fibroblastic proliferation with joint involvement. CASE-REPORT: We report the case of 2 homozygous twin brothers both presenting a diffuse and invalidating form of juvenile hyaline fibromatosis. The 2 boys' born of a twin pregnancy' presented at the age of 2 months a clinical picture made up by the classic association: infiltrated papulo-nodules, gingival hyperplasia and joint contracture. The diagnosis of juvenile hyaline fibromatosis suggested clinically was confirmed by the histological study of the skin. DISCUSSION: These observations of juvenile hyaline fibromatosis's are particular in the involvement of 2 twin brothers, which to our knowledge has never been reported, the resemblance of the clinical features, and the severity of the functional handicap.


Subject(s)
Diseases in Twins/diagnosis , Fibroma/pathology , Skin Neoplasms/pathology , Humans , Hyalin , Infant , Male
9.
Bull Soc Pathol Exot ; 95(4): 284-6, 2002 Nov.
Article in French | MEDLINE | ID: mdl-12596380

ABSTRACT

Intoxication by Atractylis gummifera L. frequently happens in Morocco. It's often accidental and mortal if no precocious and effective treatment. In order to take stock of this intoxication of which diagnosis is clinical and treatment symptomatic, we suggest to analyze one clinical case of the intoxication by Atractylis gummifera L. on a 12 year old child who accidentally ingested this plant.


Subject(s)
Atractylis/poisoning , Plant Poisoning/etiology , Abdominal Pain/etiology , Child , Coma/etiology , Diarrhea/etiology , Humans , Male , Morocco/epidemiology , Plant Poisoning/diagnosis , Plant Poisoning/epidemiology , Plant Poisoning/therapy , Respiration, Artificial , Vomiting/etiology
10.
Peptides ; 7 Suppl 1: 261-3, 1986.
Article in English | MEDLINE | ID: mdl-2875448

ABSTRACT

Biological active forms of somatostatin are produced by cleavage of large precursors. If the sequence of the pre-proform of somatostatin has been deduced from cDNA structure in several species, little is known about the processing of these large precursors. For this purpose, the analysis of immunoreactive components secreted by the R.I.N. cell line was investigated. After selection of a cell population and culture conditions providing the optimal production of these peptides, analysis of their molecular forms was done by molecular gel filtration. The results show that mainly pro-forms accumulate in the culture medium while besides the pre-proform the smaller immunoreactive species behaving like S-28 and S-14 were found in cell extracts. Incorporation studies in serum free medium showed rapid formation of an intermediate compound eluted at 1.87 V0.


Subject(s)
Islets of Langerhans/metabolism , Protein Precursors/biosynthesis , Somatostatin/biosynthesis , Animals , Cell Line , Insulin/metabolism , Insulin Secretion , Rats , Somatostatin-28
SELECTION OF CITATIONS
SEARCH DETAIL
...